DEXTROSE
5% DEXTROSE INJECTION
Approved
Approval ID
7790c2ce-2f46-7c4d-e053-2991aa0a7eda
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Feb 27, 2020
Manufacturers
FDA
HF Acquisition Co LLC, DBA HealthFirst
DUNS: 045657305
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
DEXTROSE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code51662-1306
Application NumberNDA016367
Product Classification
M
Marketing Category
C73594
G
Generic Name
DEXTROSE
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateFebruary 27, 2020
FDA Product Classification
INGREDIENTS (2)
DEXTROSE MONOHYDRATEActive
Quantity: 5 g in 100 mL
Code: LX22YL083G
Classification: ACTIB
WATERInactive
Code: 059QF0KO0R
Classification: IACT
DEXTROSE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code51662-1214
Application NumberNDA016367
Product Classification
M
Marketing Category
C73594
G
Generic Name
DEXTROSE
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateFebruary 27, 2020
FDA Product Classification
INGREDIENTS (2)
DEXTROSE MONOHYDRATEActive
Quantity: 5 g in 100 mL
Code: LX22YL083G
Classification: ACTIB
WATERInactive
Code: 059QF0KO0R
Classification: IACT